Publication | Closed Access
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
25
Citations
24
References
2023
Year
Pulmonary TuberculosisRosuvastatin Adjunctive TherapyPhase 2BTuberculosis PreventionPharmacologyTuberculosisMulticentre TrialPharmacotherapyMedicineDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1